Pre-operative Pregabalin and Ketamine to Prevent Phantom Pain

Withdrawn before enrolling · Phase 3 · Has a placebo group

Conditions studied: Phantom Pain

In brief

Phantom limb pain (PLP) is as painful sensations located to the missing limb and classified as neuropathic pain. In the United States, an estimated 1.7 million patients have undergone limb amputation, and 60% to 80% of these patients develop PLP (1-2) and it is usually resistant to a wide variety of treatments (1-4). Three factors may contribute to the development of persistent, post-amputation PLP by inducing central sensitization at different times relative to surgery: pre-amputation pain, noxious intraoperative stimuli, and acute postoperative pain (5-7). Investigators hypothesis that pre-amputation period could be important in eliminating Phantom Limb Pain (PLP) in the patients in whom cortical reorganization is not yet established. The reduction of pre-operative pain and prevention of formation of pain memories may eliminate development of PLP by using dual networks treatment strategy. This Phase III, randomized, double-blind, placebo-controlled study is designed to evaluate the efficacy of pre-operative pregabalin (lyrica) and ketamine in eliminating phantom limb pain in patients undergoing lower limb amputation.

Key facts

Study ID

NCT02311777

Run by

University of Texas Southwestern Medical Center

People needed

0

Starts

2015-05-15

Expected to finish

2017-09-20

Last updated by the study team

2018-12-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ager 18-65 years old
• Unilateral lower-limb amputations
• Able to understand study procedures
• If on opioids, patient should be on a stable dose for at least one week prior to enrolment.
• Subject with normal renal function (CrCI > 60 mL/min).

You may not qualify if…

• Cases with only digits amputation
• Current or recent history of alcohol and drug abuse
• Concomitant use of CYP 3A4 medications
• Unstable hypertension
• Abnormal EKG
• Increased intracranial pressure currently or in the past six months
• Increased intraocular pressure currently or in the past six months
• Liver disease or AST/ALT ≥ 3 ULN or total bilirubin >2 x ULN
• Poorly controlled psychiatric illness.
• A history of seizure
• Using other anticonvulsant drug
• Renal impairment as determined by clinically significant labs
• Women of childbearing age who either has:
• A positive pregnancy test
• Unprotected heterosexual sex since their previous menses or;
• Not currently using and/or willing to use a medically approved form of contraception (e.g., birth control pill)

Where it is running

• Parkland Health Hospital System — Dallas, Texas, United States
• UTSW, Parkland Hospital — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.